Synjardy

Generic name: empagliflozin and metformin

Used for: Type 2 diabetes · Lowering the risk of death from heart disease · Heart failure · Chronic kidney disease · 3 more

How do you pay?

How to pay the least

Cash price

$160+ for 30 tablets

Pharmacies pay about this for Synjardy; you’d pay more.

  1. Ask your pharmacy for Synjardy’s cash price, and one or two other pharmacies too.
  2. Synjardy’s savings card works only with insurance from a job or one you bought.

No generic is sold yet.

Compare every option

Question
Brand nameSynjardy
Authorized genericempagliflozin and metformin
Regular genericempagliflozin and metformin
What you’d pay
At least$160for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Synjardy?
The original
–
–

Brand nameThe maker’s card

SYNJARDY Savings Card (CareConnect4Me)

Savings card from Boehringer Ingelheim

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 for a 30-, 60-, or 90-day supply

Sign up on patient.boehringer-ingelheim.com 

Or call 1-866-279-8990. See the offer on patient.boehringer-ingelheim.com

In the maker’s words

“With the SYNJARDY savings card, eligible, enrolled patients may pay as little as $0 per 30-, 60-, or 90-day supply.”

From the maker’s offer on patient.boehringer-ingelheim.com, checked October 27, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Synjardy itself, from the same company, sold without the brand name, and usually for less. For now Synjardy is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

SYNJARDY

SYNJARDY is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin hydrochloride (HCl) immediate-release, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.

SYNJARDY XR

SYNJARDY XR is a combination of empagliflozin, a SGLT2 inhibitor and metformin HCl extended-release, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Empagliflozin

Empagliflozin, when used as a component of SYNJARDY or SYNJARDY XR, is indicated in adults with type 2 diabetes mellitus to reduce the risk of:

  • Cardiovascular (CV) death in adults with established CV disease.
  • CV death and hospitalization for heart failure in adults with heart failure.
  • Sustained decline in eGFR, end-stage kidney disease, CV death, and hospitalization in adults with chronic kidney disease at risk of progression.

Limitations of Use:

  • Not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. It may increase the risk of diabetic ketoacidosis in these patients.
  • Because of the metformin HCl component, the use of SYNJARDY or SYNJARDY XR is limited to patients with type 2 diabetes mellitus for all indications.
  • Empagliflozin, when used as a component of SYNJARDY or SYNJARDY XR, is not recommended for the treatment of chronic kidney disease in patients with polycystic kidney disease or patients requiring or with a recent history of intravenous immunosuppressive therapy or greater than 45 mg of prednisone or equivalent for kidney disease. Empagliflozin is not expected to be effective in these populations.

Source: the FDA label for Synjardy (Boehringer Ingelheim Pharmaceuticals, Inc.), August 25, 2026. Full label on DailyMed 

Good to know

Prices checked October 27, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/synjardy/